BDR Pharma launches BDENZA oral solution for prostate cancer
BDENZA will be available at Rs 27,000 for 150mL
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Enzalutamide
Study finds drugs used to treat prostate cancer could help treat COVID-19
Research showed that treatment with the androgen-blocking drug enzalutamide reduced TMPRSS2 levels in lab cultures of human lung…
BDR Pharma launches 80mg of Enzalutamide for prostate cancer treatment
BDR Pharmaceutical has launched 80mg advanced version of its Enzalutamide drug. Earlier the company had received the approval from…
AstraZeneca-Merck’s Lynparza gets US FDA nod for prostate cancer treatment
The drug approval by the US regulator is for treating patients with a form of prostate cancer that could not be held back by…
Zydus Cadila launches Enzalutamide to treat prostate cancer
The therapy priced at nearly two-thirds the cost of the currently available products in the market